Table 3—

Associations between breastfeeding practice and lifetime prevalence of asthma# by affluence

Affluent countries+Nonaffluent countries§
CrudeAdjustedƒCrudeAdjustedƒ
OR95% CIOR95% CIOR95% CIOR95% CI
Breastfeeding##
 No1ReferenceReference1Reference1Reference
 Yes0.870.78–0.960.870.78–0.970.930.79–1.100.890.71–1.11
Duration of breastfeeding¶¶
 Not breastfed1Reference1Reference1Reference1Reference
 <6 months0.890.77–1.030.900.77–1.041.120.90–1,391.090.86–1.39
 ≥6 months0.840.72–0.970.870.75–1.000.850,71–1.030.830.67–1.03
Exclusive breastfeeding++
 Not breastfed1Reference1Reference1Reference1Reference
 2 months0.910.79–1.050.920.79–1.061.200.96–1.501.140.91–1.44
 2–4 months0.870.76–0.990.880.77–1.010.920.68–1.230.860.63–1.17
 ≥4 months0.870.75–1.020.910.78–1.070.740.59–0.920.750.60–0.94
  • OR: odds ratio; CI: confidence interval. #: defined by parental report on asthma diagnosis; : random effect models for meta-analysis; +: gross national income (GNI) ≥US$9,200 per capita in 16 centres with 29,222 children; §: GNI <US$9,200 per capita in 11 centres with 21,851 children; ƒ: adjusted for sex, age, maternal atopic disease, environmental tobacco smoke and present bedroom sharing; ##: without Pichincha (Ecuador), for affluent countries 2,723 out of 27,550 and nonaffluent countries 1,192 out of 15,593; ¶¶: without Utrecht (the Netherlands), Pichincha (Ecuador), Ankara (Turkey) and Kintampo (Ghana), for affluent countries 2,369 out of 23,250 and nonaffluent countries 1,100 out of 14,047; ++: without Utrecht (the Netherlands), Pichincha (Ecuador) and Ankara (Turkey), for affluent countries 2,279 out of 22,091 and nonaffluent countries 1,154 out of 14,514.